It was a full house yesterday at the Broad Institute for the 2024 #Science2Startup symposium.

Thank you to everyone who joined us for a day filled with presentations, panel discussions, and networking opportunities centered around the future of the #biotech industry.

Noteworthy news out of Nvelop Therapeutics as they launch with $100M to advance research in gene editing using programmable, non-viral delivery platforms built on two in vivo validated approaches.

businesswire.com/news/home/2024…

The 2024 #Science2Startup symposium is tomorrow! After exciting discussions and powerful networking, 8 researchers will present their ideas and interact with leading investors and executives in the Boston #biotech hub.

Make sure to follow along for updates!

Thank you to #Science2Startup sponsor Colliers for hosting this year's academic workshop, “Business Plan must guide the Real Estate, not the other way around.”

To learn more about the event, please visit: science2startup.com
#biotech #pharma #startup

Thank you to #Science2Startup sponsor Silicon Valley Bank for hosting this year's academic workshop, “Banking Innovation: Considerations for Early-Stage Life Science Companies.”
To learn more about the event, please visit: science2startup.com

#biotech #pharma #startup

We run tomorrow- rain or shine (or wind/hail/snow/locusts)! Leaving at 7am from Tech Square.

#RunningAtlas

An incredible day for Diagonal Therapeutics as they launch with $128M in financing to discover and develop agonist antibodies to tackle the underlying causes of rare diseases.

globenewswire.com/news-release/2…

We're excited to share today's #Science2Startup presenter spotlight: Martin Matzuk, M.D., Ph.D.

Matzuk’s presentation will focus on: “Targeting Opportunistic Kinases for Treatment of Endometriosis”

Follow along for updates! BCMHouston From the Labs at Baylor College of Medicine

We are delighted to share the #Science2Startup class of 2024!

This year’s 8 scientific presenters were selected by an advisory group of experienced #biotech investors to present their #startup ideas on April 10th at the Broad Institute.

Learn more: science2startup.com

March Madness continues tomorrow morning with #RunningAtlas leaving from Tech Square at 7am!

We are thrilled to welcome David R. Liu to deliver the keynote address at this year’s #Science2Startup event in Cambridge on April 10.

David is a renowned business leader who has successfully launched, led, and scaled companies and products in the #healthcare space.

#RunningAtlas is happening tomorrow morning (3/21) leaving from Tech Square at 7am! #JoinUs

We’re excited to host #Science2Startup where 8 presenters from leading global academic institutions will present their startup ideas to #biotech investors and executives.

Learn more about the symposium here: science2startup.com.

Thank you to #Science2Startup ’s sponsors – Colliers, Deloitte, Evotec, Goodwin, Pliancy & Silicon Valley Bank – for making this year’s event a reality!

Learn more about the symposium, the advisors & the firms supporting the future of #biotech here: science2startup.com

Exciting day for IFM Therapeutics as Novartis acquires all outstanding capital stock of IFM Due!

Avoro Ventures' Uya Chuluunbaatar, Ph.D. will join researchers, entrepreneurs, and top investors this April for the 2024 #Science2Startup symposium!

Learn more about the event and the how it is supporting the future of #biotech : science2startup.com

We’re excited to collaborate with our amazing partners to host this year’s #Science2Startup , a symposium where the top execs, VCs, and entrepreneurs will gather in Boston to bring #biotech startup ideas to life.

Read the announcement: lnkd.in/eZxamvPr

Atlas Venture’s Kevin Bitterman, Ph.D. will join researchers, entrepreneurs, and top investors this April for the 2024 #Science2Startup symposium!

Learn more about the event and the how it is supporting the future of #biotech : science2startup.com

We are thrilled to announce that Dr. Akshay Vaishnaw has joined Atlas as a Venture Partner! We look forward to working with Akshay to build impactful new biotech companies - Welcome Akshay!!

The 4th #Science2Startup takes place this April in Cambridge, hosted by F-Prime Capital, Atlas Venture 5AM Ventures Osage Univ. Partners, MassBio, and RA Capital Management.

Learn more about this year's event, where world-class scientists connect with top investors: science2startup.com